Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

305 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Synthesis and In Vitro Comparison of DOTA, NODAGA and 15-5 Macrocycles as Chelators for the 64Cu-Labelling of Immunoconjugates.
Maisonial-Besset A, Witkowski T, Quintana M, Besse S, Gaumet V, Cordonnier A, Alliot C, Vidal A, Denevault-Sabourin C, Tarrit S, Levesque S, Miot-Noirault E, Chezal JM. Maisonial-Besset A, et al. Among authors: levesque s. Molecules. 2022 Dec 22;28(1):75. doi: 10.3390/molecules28010075. Molecules. 2022. PMID: 36615280 Free PMC article.
Phase I study of [131I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol.
Thivat E, Rouanet J, Auzeloux P, Sas N, Jouberton E, Levesque S, Billoux T, Mansard S, Molnar I, Chanchou M, Fois G, Maigne L, Chezal JM, Miot-Noirault E, D'Incan M, Durando X, Cachin F. Thivat E, et al. Among authors: levesque s. BMC Cancer. 2022 Apr 15;22(1):417. doi: 10.1186/s12885-022-09495-3. BMC Cancer. 2022. PMID: 35428211 Free PMC article.
Assessment of 99mTc-NTP 15-5 uptake on cartilage, a new proteoglycan tracer: Study protocol for a phase I trial (CARSPECT).
Thivat E, Chanchou M, Mathieu S, Levesque S, Billoux T, Auzeloux P, Sas N, Molnar I, Jouberton E, Rouanet J, Fois G, Maigne L, Galmier MJ, Penault-Llorca F, Miot-Noirault E, Durando X, Cachin F. Thivat E, et al. Among authors: levesque s. Front Med (Lausanne). 2022 Oct 12;9:993151. doi: 10.3389/fmed.2022.993151. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36314021 Free PMC article.
Imaging quality of an artificial intelligence denoising algorithm: validation in 68Ga PSMA-11 PET for patients with biochemical recurrence of prostate cancer.
Margail C, Merlin C, Billoux T, Wallaert M, Otman H, Sas N, Molnar I, Guillemin F, Boyer L, Guy L, Tempier M, Levesque S, Revy A, Cachin F, Chanchou M. Margail C, et al. Among authors: levesque s. EJNMMI Res. 2023 May 25;13(1):50. doi: 10.1186/s13550-023-00999-y. EJNMMI Res. 2023. PMID: 37231229 Free PMC article.
Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma.
Biau J, Thivat E, Chautard E, Stefan D, Boone M, Chauffert B, Bourgne C, Richard D, Molnar I, Levesque S, Bellini R, Kwiatkowski F, Karayan-Tapon L, Verrelle P, Godfraind C, Durando X. Biau J, et al. Among authors: levesque s. Radiother Oncol. 2021 Jan;154:227-234. doi: 10.1016/j.radonc.2020.09.036. Epub 2020 Sep 22. Radiother Oncol. 2021. PMID: 32976869 Clinical Trial.
Improving prime editing with an endogenous small RNA-binding protein.
Yan J, Oyler-Castrillo P, Ravisankar P, Ward CC, Levesque S, Jing Y, Simpson D, Zhao A, Li H, Yan W, Goudy L, Schmidt R, Solley SC, Gilbert LA, Chan MM, Bauer DE, Marson A, Parsons LR, Adamson B. Yan J, et al. Among authors: levesque s. Nature. 2024 Apr;628(8008):639-647. doi: 10.1038/s41586-024-07259-6. Epub 2024 Apr 3. Nature. 2024. PMID: 38570691 Free PMC article.
305 results